CLINICAL_TRIALS
trial_result
· 2020-04-22
Clinical Trial Update: Sorafenib + mFOLFOX for Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 trial evaluating sorafenib in combination with mFOLFOX for hepatocellular carcinoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Hepatocellular Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-04-22